Compositions for inhibiting teratoma formation and growth comprising timp-1 and timp-2 as effective components
AssigneeKorea University Research and Business Foundation
InventorsSung Hoi HONG, Kyung-Ah CHOI
Life of this patent
Estimating the term…
Loading patent…
AssigneeKorea University Research and Business Foundation
InventorsSung Hoi HONG, Kyung-Ah CHOI
Estimating the term…
The present invention relates to a composition for inhibiting teratoma formation or growth, comprising tissue inhibitor of metalloproteinase 1 (TIMP-1) or tissue inhibitor of metalloproteinase 2 (TIMP-2) as an effective component. A pharmaceutical composition for inhibiting teratoma formation or growth comprising TIMP-1 or TIMP-2 as an effective component according to the present invention, when used in stem cell therapy, can inhibit the formation and growth of teratomas caused by undifferentiated pluripotent stem cells, without affecting the differentiation potential thereof, and thus can be advantageously used as a combination drug in combination with a stem cell drug.
1-9. (canceled)
A method for inhibiting teratoma formation or growth comprising administering a composition comprising TIMP-1 or TIMP-2 as an active ingredient to a subject in need thereof.
A method for producing a composition for inhibiting teratoma formation or growth comprising TIMP-1 or TIMP-2 as an active ingredient, the method comprising steps of:
Dependencies are inferred from the claim text.